| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| 8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 1b from ORIGENE TECHNOLOGIES | LY413835 | 100 ug | ORIGENE TECHNOLOGIES |
| 8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 1b from ORIGENE TECHNOLOGIES | LY429520 | 100 ug | ORIGENE TECHNOLOGIES |
| 8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 2b from ORIGENE TECHNOLOGIES | LY413813 | 100 ug | ORIGENE TECHNOLOGIES |
| 8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 2d from ORIGENE TECHNOLOGIES | LY413815 | 100 ug | ORIGENE TECHNOLOGIES |
| 8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 2e from ORIGENE TECHNOLOGIES | LY413816 | 100 ug | ORIGENE TECHNOLOGIES |
| 8-oxoguanine DNA glycosylase (OGG1), nuclear gene encoding mitochondrial protein, transcript variant 2e from ORIGENE TECHNOLOGIES | LY429526 | 100 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (APOBEC3A) from ORIGENE TECHNOLOGIES | TP320995 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 (APOBEC2) from ORIGENE TECHNOLOGIES | TP308399 | 20 ug | ORIGENE TECHNOLOGIES |
| 3-oxoacyl-ACP synthase, mitochondrial (OXSM), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIES | LY413479 | 100 ug | ORIGENE TECHNOLOGIES |
| AMBRA1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406255 | 1 kit | ORIGENE TECHNOLOGIES |
| AMBRA1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH306255 | 10 ug | ORIGENE TECHNOLOGIES |
| Ambra1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501181 | 1 kit | ORIGENE TECHNOLOGIES |
| ASPG - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418090 | 1 kit | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 1 (MS4A1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY407182 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 1 (MS4A1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY402889 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 12 (MS4A12), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413597 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 12 (MS4A12), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431179 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 15 (MS4A15), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407337 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412040 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404181 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), transcript variant 3 from ORIGENE TECHNOLOGIES | LY404182 | 100 ug | ORIGENE TECHNOLOGIES |
| Membrane-spanning 4-domains, subfamily A, member 13 (MS4A13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422855 | 100 ug | ORIGENE TECHNOLOGIES |
| CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae) (CLP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402047 | 100 ug | ORIGENE TECHNOLOGIES |
| CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae) (CLP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428198 | 100 ug | ORIGENE TECHNOLOGIES |
| CLP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401772 | 1 kit | ORIGENE TECHNOLOGIES |
| Clp1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503482 | 1 kit | ORIGENE TECHNOLOGIES |
| CLP1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301772 | 10 ug | ORIGENE TECHNOLOGIES |
| ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli) (CLPP), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIES | LY416925 | 100 ug | ORIGENE TECHNOLOGIES |
| CLPP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400301 | 1 kit | ORIGENE TECHNOLOGIES |
| Clpp - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503484 | 1 kit | ORIGENE TECHNOLOGIES |
| CLPP Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300301 | 10 ug | ORIGENE TECHNOLOGIES |
| CLPS - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405004 | 1 kit | ORIGENE TECHNOLOGIES |
| Clps - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503485 | 1 kit | ORIGENE TECHNOLOGIES |
| CLPSL2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416171 | 1 kit | ORIGENE TECHNOLOGIES |
| CLPSL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422081 | 1 kit | ORIGENE TECHNOLOGIES |
| Clpsl2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503486 | 1 kit | ORIGENE TECHNOLOGIES |
| PHOSPHO1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH314434 | 10 ug | ORIGENE TECHNOLOGIES |
| Recombinant extracellular domain of human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP700010 | 20 ug | ORIGENE TECHNOLOGIES |
| Cyclin D binding myb-like transcription factor 1 (DMTF1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412065 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin D2 (CCND2) from ORIGENE TECHNOLOGIES | LY419750 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin D1 (CCND1) from ORIGENE TECHNOLOGIES | LY403284 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin D3 (CCND3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400666 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 4 from ORIGENE TECHNOLOGIES | LY429923 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 4 from ORIGENE TECHNOLOGIES | LY409229 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 5 from ORIGENE TECHNOLOGIES | LY434008 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409213 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409193 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417638 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429931 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) from ORIGENE TECHNOLOGIES | LY401318 | 100 ug | ORIGENE TECHNOLOGIES |